BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8186662)

  • 1. Intracavernous prostaglandin E1 in erectile dysfunction.
    Linet OI; Neff LL
    Clin Investig; 1994 Jan; 72(2):139-49. PubMed ID: 8186662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction.
    Kunelius P; Lukkarinen O
    Int J Impot Res; 1999 Feb; 11(1):21-4. PubMed ID: 10098949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of PGE1 in the treatment of erectile deficiency].
    Arena F; Peracchia G; Di Stefano C; Cortellini P
    Acta Biomed Ateneo Parmense; 1996; 67(1-2):49-53. PubMed ID: 10021734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial experiences with prostaglandin E1 and PGE1 prepared injections].
    Mattarelli G; Leibundgut B
    Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism.
    Schramek P; Dorninger R; Waldhauser M; Konecny P; Porpaczy P
    Br J Urol; 1990 Jan; 65(1):68-71. PubMed ID: 2310934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L; Wen J; Jiang X; Chen H; Tang Y
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological erection program using prostaglandin E1.
    Gerber GS; Levine LA
    J Urol; 1991 Sep; 146(3):786-9. PubMed ID: 1875494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostaglandin E1 in the long-term treatment of erectile dysfunction].
    Vrabec J
    Bratisl Lek Listy; 1992 Oct; 93(10):545-6. PubMed ID: 1288824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
    Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
    Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavernous injection of prostaglandin E1 in impotent men.
    Stackl W; Hasun R; Marberger M
    J Urol; 1988 Jul; 140(1):66-8. PubMed ID: 3379700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
    Staerman F; Veilhan LA; Guiraud P; Coeurdacier P; Cipolla B; Lobel B
    Prog Urol; 1996; 6(4):564-8. PubMed ID: 8924934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
    Loran OB; Segal AS; Shcheplev PA
    Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence.
    Ishii N; Watanabe H; Irisawa C; Kikuchi Y; Kubota Y; Kawamura S; Suzuki K; Chiba R; Tokiwa M; Shirai M
    J Urol; 1989 Feb; 141(2):323-5. PubMed ID: 2913354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martínez-Piñeiro L; Cortés R; Cuervo E; López-Tello J; Cisneros J; Martínez-Piñeiro JA
    Eur Urol; 1998 Oct; 34(4):350-4. PubMed ID: 9748684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence.
    Wang CJ; Wu CC; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):585-90. PubMed ID: 1296038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Office treatment: intracavernous injections of prostaglandin E1 (PG E1) and improvement of spontaneous erections.
    Beretta G; Marzotto M; Zanollo A; Re B
    Acta Eur Fertil; 1991; 22(4):221-3. PubMed ID: 1844326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.